Aveo Pharmaceuticals, Inc.
AVEODelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001325879
Aveo Pharmaceuticals, Inc. was delisted in 2023; its insiders filed their last Form 4 on Jan 19, 2023; 110 institutions reported holding it in 13F filings for Q4 2022, worth $375.1M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Aveo Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Aveo Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Bate Kenneth | Director | 375 | Jan 19, 2023 | 0 |
| Evnin Anthony B | Director | 0 | Jan 19, 2023 | 0 |
| Bailey Michael P | President & CEO | 0 | Jan 19, 2023 | 0 |
| Mayes, Gregory T. | Director | – | Jan 19, 2023 | 0 |
| Lucera Erick | Chief Financial Officer | – | Jan 19, 2023 | 0 |
| Spring Scarlett | Director | – | Jan 19, 2023 | 0 |
| Epperly Corinne | Director | – | Jan 19, 2023 | 0 |
| Ferraresso Michael | Chief Commercial Officer | 0 | Jan 19, 2023 | 0 |
| Cullen Kevin Joseph | Director | – | Jan 19, 2023 | 0 |
| Ledell Jebediah | Chief Operating Officer | – | Jan 19, 2023 | 0 |
| NEA Partners 15, L.P. | 10% Owner | 0 | Oct 21, 2022 | 0 |
| Nea 15 GP, LLC | 10% Owner | 0 | Oct 21, 2022 | 0 |
| Sandell Scott D | 10% Owner | 386Indirect | Oct 21, 2022 | 0 |
| Baskett Forest | 10% Owner | 3,220Indirect | Oct 21, 2022 | 0 |
| Sonsini Peter W. | 10% Owner | 24Indirect | Oct 21, 2022 | 0 |
| Florence Anthony A. Jr. | 10% Owner | 354Indirect | Oct 21, 2022 | 0 |
| New Enterprise Associates 15, L.P. | 10% Owner | 0 | Oct 21, 2022 | 0 |
| Makhzoumi Mohamad | 10% Owner | 559 | Oct 21, 2022 | 0 |
| Growth Equity Opportunities Fund IV, LLC | 10% Owner | 0 | Oct 21, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2021 (view filing) | Sep 1 | 2 days | Bailey Michael PPresident & CEO | PPurchase | +15.0K | $6.48 | +$97.2K | +43.7%49.3K after | |
| Aug 11, 2021 (view filing) | Aug 10 | 1 day | Ferraresso MichaelChief Commercial Officer | PPurchase | +2.61K | $5.75 | +$15.0K | +45.7%8.32K after |